Mr Andurand is the founder and Chief Investment Officer of Andurand Capital and was previously founder and Chief Investment Officer at BlueGold, both global commodities hedge funds with peak assets of US$1.6bn and US$2.4bn under management, respectively. Mr Andurand’s previous career was as an energy trader at Vitol SA where he was Partner, before that at Bank of America and formerly at Goldman Sachs. He holds a Masters in International Finance from HEC, Paris and an Engineering Degree in Applied Mathematics from INSA, Toulouse, France.
Dr Choo is Chairman of Plasticell Ltd and of Progenitor Labs Ltd. He is the founder of Plasticell and served as Chief Executive and Chief Scientist of the company. Prior to his interest in stem cells he was a founder and Chief Scientist of Gendaq (acquired by Sangamo Biosciences), a biotech company that developed the zinc finger technology now used for gene editing. Previously he was a staff scientist at the MRC Laboratory of Molecular Biology, Cambridge, where he pioneered the engineering of protein-DNA interactions using combinatorial methods under Nobel laureate Sir Aaron Klug. Dr Choo holds a PhD in Molecular Biology from the University of Cambridge and for his thesis received the Prize for Young Scientists awarded by GE Healthcare and Science (1996), and the Max Perutz Student Prize awarded by MRC-LMB (1995). He sits on the UK Stem Cell Steering Committee which oversees national stem cell research and the UK Stem Cell Bank .